Escitalopram in clinical practice: Results of an observational study in patients with depression and anxiety;Escitalopram in der klinischen praxis: Eine erhebung von praxiserfahrungen bei patienten mit depressionen und angststörungen

Psychopharmakotherapie

Volumn 18, Issue 2, 2011, Pages 59-65

  Holsboer Trachsler, Edith ^a   Baumann, Pierre ^b   Höck, Paul ^c   Hättenschwiler, Josef ^d   Jost, Martin ^c   Ramseier, Fritz ^e   Seifritz, Erich ^f   Nil, Rico ^g  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Hopital de Cery   (Switzerland)

^c Zentrum für Angst und Depressionsbehandlung ZADZ ^*  (Switzerland)

^d Jiri Modestin Zentrum für Angst und Depressionsbehandlung Zürich ZADZ   (Switzerland)

^e Psychiatrische Klinik   (Switzerland)

^f UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^g H LUNDBECK A S   (Denmark)

Author keywords

Comorbidity; Depression; Escitalopram; Observational study

Indexed keywords

ESCITALOPRAM;

ADL DISABILITY; ANXIETY DISORDER; ARTICLE; CLINICAL PRACTICE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIVATE PRACTICE; PSYCHIATRIST; QUESTIONNAIRE; REMISSION; SWITZERLAND; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 79954561265     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Baldwin DS, Huusom AKT, Maehlum E. Escitalopram and paroxetine in the treatment of generalised anxiety disorder. Br J Psychiatry 2006;189:264-72.
2. Bauer M, Bschor T, Pfennig A, Whybrow PC, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007;8:67-104. (Pubitemid 46690921)
3. Boulenger JP, Huusom AKT, Florea I, Bækdal T, et al. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. Curr Med Res Opin 2006;22:1331-41.
4. Holsboer-Trachsler E, Vanoni C. Depression in der Praxis. Wessobrunn: Socio-medico Verlag, 2007.
5. Kennedy SH, Andersen HF, Lam RW. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective Serotonine reuptake inhibitors and venlafaxine XR: a meta-analysis. J Psychiatry Neurosci 2006;31:122-31.
6. Khan A, Bose A, Alexopoulos GS, Gommoll C, et al. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder. Clin Drug Invest 2007;27:481-92. (Pubitemid 46919700)
7. Lader M, Stender K, Bürger V, Nil R. Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study. Depress Anxiety 2004;19:241-8. (Pubitemid 39014144)
8. Laux G, Friede M. Escitalopram zur Behandlung von komorbider Angst und Depression. Psychopharmakotherapie 2009;16:106-13.
9. Möller HJ, Langer S, Schmauss M. Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany. Pharmacopsychiatry 2007;40:53-7. (Pubitemid 46697675)
10. Montgomery SA, Huusom AKT, Bothmer J. A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder. Neuropsychobiology 2004;50:57-64. (Pubitemid 38721171)
11. Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 2005;20:131-7. (Pubitemid 40571510)
12. Rush AJ, Bose A. Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting. Depress Anxiety 2005;21:26-32. (Pubitemid 40614546)
13. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-17. (Pubitemid 44807782)
14. Sánchez C, Bøgesø KP, Ebert B, Reines EH, et al. Escitalopram versus citalopram: the surprising role of the R-enantiomer. Psychopharmacology 2004;174:163-76. (Pubitemid 38916289)
15. Stassen HH, Angst J, Delini-Stula A. Delayed onset of action of antidepressant drugs? Survey of results of meta-analyses. Pharmacopsychiatry 1996;29:87-96. (Pubitemid 26150434)
16. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163:28-40. (Pubitemid 43050100)
17. Wade A, Gembert K, Florea I. A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder. Curr Med Res Opin 2007;23:1605-14. (Pubitemid 47122170)